GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for individuals with and without diabetes. Social media platforms’ users started promoting semaglutide/Ozempic as a weight-loss treatment, and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Arillotta, Davide, Floresta, Giuseppe, Guirguis, Amira, Corkery, John Martin, Catalani, Valeria, Martinotti, Giovanni, Sensi, Stefano L., Schifano, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669484/
https://www.ncbi.nlm.nih.gov/pubmed/38002464
http://dx.doi.org/10.3390/brainsci13111503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669484/
https://www.ncbi.nlm.nih.gov/pubmed/38002464
http://dx.doi.org/10.3390/brainsci13111503

Ejemplares similares